Submitted by Anonymous (not verified) on 22 October 2025 - 10:55
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 19, Status: Authorised